Ceftriaxone sodium and Adrenal insufficiency - a phase IV clinical study of FDA data

Summary:

Adrenal insufficiency is reported as a side effect among people who take Ceftriaxone sodium (ceftriaxone sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cortril, and have Fever.

The phase IV clinical study analyzes which people have Adrenal insufficiency when taking Ceftriaxone sodium. It is created by eHealthMe based on reports of 6,546 people who have side effects when taking Ceftriaxone sodium from the FDA, and is updated regularly.

What is Ceftriaxone sodium?

Ceftriaxone sodium has active ingredients of ceftriaxone sodium. eHealthMe is studying from 6,549 Ceftriaxone sodium users. Check the latest studies of Ceftriaxone sodium.

What is Adrenal insufficiency?

Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids) is found to be associated with 967 drugs and 1,094 conditions by eHealthMe. Check the latest studies of Adrenal insufficiency.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

6,546 people reported to have side effects when taking Ceftriaxone sodium.
Among them, 12 people (0.18%) have Adrenal insufficiency.

Could Ceftriaxone sodium cause Adrenal insufficiency?

Among these 12 people:

How long have people been on Ceftriaxone sodium when they have Adrenal insufficiency? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Adrenal insufficiency when taking Ceftriaxone sodium? *

  • female: 41.67 %
  • male: 58.33 %

What is the age of people who have Adrenal insufficiency when taking Ceftriaxone sodium? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 8.33 %
  • 50-59: 0.0 %
  • 60+: 91.67 %

What are other drugs people take besides Ceftriaxone sodium? *

  1. Cortril: 7 people, 58.33%
  2. Opdivo: 2 people, 16.67%
  3. Dexamethasone: 2 people, 16.67%
  4. Cymbalta: 2 people, 16.67%
  5. Yervoy: 2 people, 16.67%
  6. Cyclophosphamide: 2 people, 16.67%
  7. Maxipime: 2 people, 16.67%
  8. Meropenem: 2 people, 16.67%
  9. Neoral: 2 people, 16.67%
  10. Zometa: 2 people, 16.67%

What are other side effects people have besides Adrenal insufficiency? *

  1. Fever: 6 people, 50.00%
  2. Pneumonia: 4 people, 33.33%
  3. Thrombocytopenia (decrease of platelets in blood): 4 people, 33.33%
  4. Hepatic Function Abnormal: 3 people, 25.00%
  5. Toxic Skin Eruption (skin breakdown due to toxic substance): 2 people, 16.67%
  6. Interstitial Lung Disease: 2 people, 16.67%
  7. Cholangitis (infection of the bile duct): 2 people, 16.67%
  8. Cholecystitis (infection of gallbladder): 2 people, 16.67%
  9. Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 2 people, 16.67%
  10. Death: 2 people, 16.67%

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 3 people, 25.00%
  2. Fever: 3 people, 25.00%
  3. Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
  4. Cholecystitis (infection of gallbladder): 2 people, 16.67%
  5. Pneumonia: 2 people, 16.67%
  6. Oesophageal Carcinoma (cancer tumour of oesophagus): 2 people, 16.67%
  7. Neuropathy Peripheral (surface nerve damage): 2 people, 16.67%
  8. Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 2 people, 16.67%
  9. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 16.67%
  10. Sheehan Syndrome (severe bleeding during childbirth can result in tissue death in the pituitary gland. this causes the gland to lose its ability to work properly): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone sodium and have Adrenal insufficiency?

- Check whether Adrenal insufficiency is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone sodium:

Adrenal insufficiency treatments and more:

How severe was Adrenal insufficiency and when was it recovered:

Expand to all the drugs that have ingredients of ceftriaxone sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftriaxone sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Adrenal insufficiency:

Browse all the conditions that are associated with Adrenal insufficiency:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone sodium) and Ceftriaxone sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: